Login Register Cart 0
Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Short Communication

Synthesis, Molecular Docking, and In vitro Antimycobacterial Studies on N'-arylidene-4-nitrobenzohydrazides

Author(s): Dinesh Bhosale, Suraj N. Mali, Bapu R. Thorat*, Swati S. Wavhal, Devidas S. Bhagat and Ravikumar M. Borade

Volume 17, Issue 1, 2022

Published on: 05 August, 2022

Page: [69 - 83] Pages: 15

DOI: 10.2174/1570193X19666220531154544

Price: $65

conference banner
Abstract

Background: Mycobacterium tuberculosis (Mtb) is an organism that causes tuberculosis (TB). In 2019, 10 million individuals worldwide contracted tuberculosis, with 1.4 million people dying from the disease each year (World Health Organization, 2021). Hydrazones- hydrazide-based drugs have been shown to be bactericidal against M. tuberculosis replication.

Objectives: We herein intended to synthesize a series of acid hydrazones (3a-3l) by condensing 4-nitrobenzohydrazine with substituted aromatic acids in ethanol at room temperature.

Materials and Methods: All newly synthesized compounds were characterized by standard spectroscopic techniques. Synthesized compounds were then tested for anti-mycobacterial activity against H37Rv strains. Molecular docking analysis was performed for three crystal structures of 1ENY, 1TED and 2FUM Mycobacterium tuberculosis receptors.

Results: Among all tested molecules, 3i (MIC: 50 μg/mL) and 3b (MIC: 50 μg/mL) were found to be the best ligands for further development of new anti-TB drug. We found that our proposed molecules have higher docking scores, corresponding standard anti-TB agents, such as ciprofloxacin and isoniazid. Synthesized compounds were found to have druglikeness properties when tested with Lipinski’s filter for drug-likeness.

Conclusion: Our current study proposes N'-arylidene-4-nitrobenzohydrazides as anti-TB agents. Agents with such system can be developed in future for development into active lead molecules.

Keywords: Acid hydrazones, 4-nitrobenzohydrazide, molecular docking, 1ENY, 1TED, 2FUM.

« Previous Next »
[1]
Martins GM, Corrêa de Carvalho R, Silva C-BF, Boechat N, Duarte PNA. Ferreira de C.M.F. The cleavage kinetics of hydrazide derivatives of isoniazid by HPLC-UV/DAD and its impact on activity against Mycobacterium tuberculosis. J Chromatogr B Analyt Technol Biomed Life Sci 2022; 1188123080
[http://dx.doi.org/10.1016/j.jchromb.2021.123080] [PMID: 34923301]
[2]
Mali SN, Thorat BR, Gupta DR, Pandey A. Mini-review of the importance of hydrazides and their derivatives-synthesis and biological activity. Eng Proc 2021; 11(1): 21.
[3]
Mathew B, Suresh JJ, Ahsan ME, et al. Hydrazones as a privileged structural linker in antitubercular agents: A review Infec Disorders-Drug Targ (Formerly Current Drug Targets-Infectious Disorders) 2015; 15(2): 76-88.
[http://dx.doi.org/ 10.2174/1871526515666150724104411]
[4]
Pandeya SN, Raja AS, Stables JP. Synthesis of isatin semicarbazones as novel anticonvulsants-role of hydrogen bon-ding. J Pharm Pharm Sci 2002; 5(3): 266-71.
[PMID: 12553895]
[5]
Aggarwal N, Aggarwal R, Mishra P, Jain JS, Bansal SK, Jha KK. Design and evaluation of semicarbazones and thiose-micarbazones as novel anticonvulsants. Cent Nerv Syst Agents Med Chem 2008; 8(1): 26-8.
[http://dx.doi.org/10.2174/187152408783790596]
[6]
Aggarwal N, Mishra P, Nagori BP, Aggarwal R, Jain J. Anticonvulsant and neurotoxicity evaluation of some N(4) phenyl substituted pyridyl semicarbazones. Cent Nerv Syst Agents Med Chem 2009; 9(4): 295-9.
[http://dx.doi.org/10.2174/187152409789630442] [PMID: 20021362]
[7]
Singh A, Pande C, Gahtori P, Pandeya SN, Stables JP. Design and synthesis of some novel 4-(4- substituted aryl) semi-carbazones as anticonvulsant agents. Indian J Pharm Sci 2010; 72(3): 363-7.
[http://dx.doi.org/10.4103/0250-474X.70485] [PMID: 21188048]
[8]
Singh P, Jain J, Sinha R, Samad A, Kumar R, Malhotra M. Synthesis and screening of substituted thiosemicarbazone derivatives: An approach towards novel anticonvulsant search. Cent Nerv Syst Agents Med Chem 2011; 11(1): 60-5.
[http://dx.doi.org/10.2174/187152411794961112] [PMID: 21294704]
[9]
Belkheiri N, Bouguerne B, Bedos-Belval F, et al. Synthesis and antioxidant activity evaluation of a syringic hydrazones family. Eur J Med Chem 2010; 45(7): 3019-26.
[http://dx.doi.org/10.1016/j.ejmech.2010.03.031] [PMID: 20403645]
[10]
Rane RA, Telvekar VN. Synthesis and evaluation of novel chloropyrrole molecules designed by molecular hybridization of common pharmacophores as potential antimicrobial agents. Bioorg Med Chem Lett 2010; 20(19): 5681-5.
[http://dx.doi.org/10.1016/j.bmcl.2010.08.026] [PMID: 20800487]
[11]
Bawa S, Kumar S, Drabu S, Kumar R. Synthesis and antimicrobial activity of 2-chloro-6- methylquinoline hydrazone derivatives. J Pharm Bioallied Sci 2009; 1(1): 27-31.
[http://dx.doi.org/10.4103/0975-7406.62683]
[12]
Kaplancikli ZA, Altintop MD, Özdemir A, Turan-Zitounia G, Khan SI, Tabanca N. Synthesis and biological evaluation of some hydrazone derivatives as anti-inflammatory agents. Lett Drug Des Discov 2012; 9: 310-5.
[http://dx.doi.org/10.2174/157018012799129828]
[13]
Hu WX, Zhou W, Xia CN, Wen X. Synthesis and anticancer activity of thiosemicarbazones. Bioorg Med Chem Lett 2006; 16(8): 2213-8.
[http://dx.doi.org/10.1016/j.bmcl.2006.01.048] [PMID: 16458509]
[14]
Congiu C, Onnis V. Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents. Bioorg Med Chem 2013; 21(21): 6592-9.
[http://dx.doi.org/10.1016/j.bmc.2013.08.026] [PMID: 24071449]
[15]
Küçükgüzela SG, Rollas S, Küçükgüzel I, Kiraz M. Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur J Med Chem 1999; 34(12): 1093-100.
[http://dx.doi.org/10.1016/S0223-5234(99)00129-4]
[16]
Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: A novel class of potential antibacterial and antituber-cular agents. Eur J Med Chem 2008; 43(9): 1989-96.
[http://dx.doi.org/10.1016/j.ejmech.2007.11.016] [PMID: 18207286]
[17]
Raparti V, Chitre T, Bothara K, et al. Novel 4-(morpholin-4-yl)-N-(arylidene)benzohydrazides: Synthesis, antimyco-bacterial activity and QSAR investigations. Eur J Med Chem 2009; 44(10): 3954-60.
[http://dx.doi.org/10.1016/j.ejmech.2009.04.023] [PMID: 19464085]
[18]
Desale VJ, Mali SN, Thorat BR, Yamgar RS. Synthesis, admetSAR predictions, DPPH radical scavenging activity, and potent anti-mycobacterial studies of hydrazones of substituted 4-(anilino methyl) benzohydrazides (Part 2). Curr Computeraided Drug Des 2021; 17(4): 493-503.
[http://dx.doi.org/10.2174/1573409916666200615141047] [PMID: 32538732]
[19]
Mali SN, Pandey A. Greener synthesis, in-silico and the-oretical analysis of hydrazides as potential antituberculosis agents (Part 1)†. In Chem Proc In: 2021. 3
[20]
Desale VJ, Mali SN, Chaudhari HK, Mali MC, Thorat BR, Yamgar RS. Synthesis and anti-mycobacterium study on halo-substituted 2-aryl oxyacetohydrazones. Curr Computeraided Drug Des 2020; 16(5): 618-28.
[http://dx.doi.org/10.2174/1573409915666191018120611] [PMID: 31648645]
[21]
(a) Thorat BR, Rani D, Yamgar RS, Mali SN. Synthesis, spectroscopic, in-vitro and computational analysis of hydra-zones as potential antituberculosis agents:(part-I). Comb Chem High Throughput Screen 2020; 23(5): 392-401.
[http://dx.doi.org/10.2174/1386207323999200325125858] [PMID: 32209038] ; (b) Nguta JM, Appiah-Opong R, Nyarko AK, et al. In vitro antimycobacterial and cytotoxic data on medicinal plants used to treat tuberculosis. Data Brief 2016; 7: 1124-30.
[http://dx.doi.org/10.1016/j.dib.2016.03.088] [PMID: 27115026]
[22]
LigPrep NY: Schrodinger, LLC 2021. Available from: 2021.https://www.schrodinger.com/products/ligprep
[23]
Protein Database Bank Available from: https://www.rcsb.org/(Accessed on 18-05-2022)

Rights & Permissions Print Cite
Article Metrics
13
© 2024 Bentham Science Publishers | Privacy Policy